6967. Safety and immunogenicity of a mosquito saliva peptide-based vaccine: a randomised, placebo-controlled, double-blind, phase 1 trial.
作者: Jessica E Manning.;Fabiano Oliveira.;Iliano V Coutinho-Abreu.;Samantha Herbert.;Claudio Meneses.;Shaden Kamhawi.;Holly Ann Baus.;Alison Han.;Lindsay Czajkowski.;Luz Angela Rosas.;Adriana Cervantes-Medina.;Rani Athota.;Susan Reed.;Allyson Mateja.;Sally Hunsberger.;Emma James.;Olga Pleguezuelos.;Gregory Stoloff.;Jesus G Valenzuela.;Matthew J Memoli.
来源: Lancet. 2020年395卷10242期1998-2007页
In animal models, immunity to mosquito salivary proteins protects animals against mosquito-borne disease. These findings provide a rationale to vaccinate against mosquito saliva instead of the pathogen itself. To our knowledge, no vector salivary protein-based vaccine has been tested for safety and immunogenicity in humans. We aimed to assess the safety and immunogenicity of Anopheles gambiae saliva vaccine (AGS-v), a peptide-based vaccine derived from four A gambiae salivary proteins, in humans.
6968. Have deaths from COVID-19 in Europe plateaued due to herd immunity?
作者: Lucy C Okell.;Robert Verity.;Oliver J Watson.;Swapnil Mishra.;Patrick Walker.;Charlie Whittaker.;Aris Katzourakis.;Christl A Donnelly.;Steven Riley.;Azra C Ghani.;Axel Gandy.;Seth Flaxman.;Neil M Ferguson.;Samir Bhatt.
来源: Lancet. 2020年395卷10241期e110-e111页 6969. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.
作者: Silvia Stringhini.;Ania Wisniak.;Giovanni Piumatti.;Andrew S Azman.;Stephen A Lauer.;Hélène Baysson.;David De Ridder.;Dusan Petrovic.;Stephanie Schrempft.;Kailing Marcus.;Sabine Yerly.;Isabelle Arm Vernez.;Olivia Keiser.;Samia Hurst.;Klara M Posfay-Barbe.;Didier Trono.;Didier Pittet.;Laurent Gétaz.;François Chappuis.;Isabella Eckerle.;Nicolas Vuilleumier.;Benjamin Meyer.;Antoine Flahault.;Laurent Kaiser.;Idris Guessous.
来源: Lancet. 2020年396卷10247期313-319页
Assessing the burden of COVID-19 on the basis of medically attended case numbers is suboptimal given its reliance on testing strategy, changing case definitions, and disease presentation. Population-based serosurveys measuring anti-severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2) antibodies provide one method for estimating infection rates and monitoring the progression of the epidemic. Here, we estimate weekly seroprevalence of anti-SARS-CoV-2 antibodies in the population of Geneva, Switzerland, during the epidemic.
6971. Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000-17: analysis for the Global Burden of Disease Study 2017.
Across low-income and middle-income countries (LMICs), one in ten deaths in children younger than 5 years is attributable to diarrhoea. The substantial between-country variation in both diarrhoea incidence and mortality is attributable to interventions that protect children, prevent infection, and treat disease. Identifying subnational regions with the highest burden and mapping associated risk factors can aid in reducing preventable childhood diarrhoea.
6976. Quality of primary health care in China: challenges and recommendations.
作者: Xi Li.;Harlan M Krumholz.;Winnie Yip.;Kar Keung Cheng.;Jan De Maeseneer.;Qingyue Meng.;Elias Mossialos.;Chuang Li.;Jiapeng Lu.;Meng Su.;Qiuli Zhang.;Dong Roman Xu.;Liming Li.;Sharon-Lise T Normand.;Richard Peto.;Jing Li.;Zengwu Wang.;Hongbing Yan.;Runlin Gao.;Somsak Chunharas.;Xin Gao.;Raniero Guerra.;Huijie Ji.;Yang Ke.;Zhigang Pan.;Xianping Wu.;Shuiyuan Xiao.;Xinying Xie.;Yujuan Zhang.;Jun Zhu.;Shanzhu Zhu.;Shengshou Hu.
来源: Lancet. 2020年395卷10239期1802-1812页
China has substantially increased financial investment and introduced favourable policies for strengthening its primary health care system with core responsibilities in preventing and managing chronic diseases such as hypertension and emerging infectious diseases such as coronavirus disease 2019 (COVID-19). However, widespread gaps in the quality of primary health care still exist. In this Review, we aim to identify the causes for this poor quality, and provide policy recommendations. System challenges include: the suboptimal education and training of primary health-care practitioners, a fee-for-service payment system that incentivises testing and treatments over prevention, fragmentation of clinical care and public health service, and insufficient continuity of care throughout the entire health-care system. The following recommendations merit consideration: (1) enhancement of the quality of training for primary health-care physicians, (2) establishment of performance accountability to incentivise high-quality and high-value care; (3) integration of clinical care with the basic public health services, and (4) strengthening of the coordination between primary health-care institutions and hospitals. Additionally, China should consider modernising its primary health-care system through the establishment of a learning health system built on digital data and innovative technologies.
|